comparemela.com

Latest Breaking News On - Events reporting system - Page 7 : comparemela.com

Doctor says US "wasting money" on coronavirus drug from Merck

A critical care doctor said the U.S. is wasting taxpayer's money on its purchase of drug manufacturer Merck's Wuhan coronavirus (COVID-19) antiviral treatment. Front Line COVID-19 [.]

Wuhan
Hubei
China
Mexico-city
Distrito-federal
Mexico
Mexicans
Ridgeback-biotherapeutics
Claudia-sheinbaum
Pierre-kory
Gilead-sciences
Department-of-health

US Spending $1.2 Billion on Merck's COVID-19 Treatment Is a 'Waste of Taxpayers' Money': Doctor

US Spending $1.2 Billion on Merck's COVID-19 Treatment Is a 'Waste of Taxpayers' Money': Doctor
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Toronto
Ontario
Canada
Mexico
Mexico-city
Distrito-federal
China
United-states
Chinese
Americans
Ridgeback-biotherapeutics
Pierre-kory

Three New Zantac Studies Confirm Cancer Risks

Three New Zantac Studies Confirm Cancer Risks From:   Los Angeles, Calif., April 6, 2021 - - The results from three new Zantac studies confirm the popular drug contains high levels of a cancer-causing agent (NDMA) and increases the risk of developing several types of cancer. The studies, one from Memorial Sloan Kettering Cancer Center, one from online pharmacy Valisure, and another from the University of Alabama at Birmingham, all found that at a minimum, Zantac (ranitidine) exposes users to substantial amounts of NDMA and may increase the risk of developing: Bladder cancer Thyroid cancer One of the things we have said from the very beginning is this litigation is not about a contaminated drug – this drug is defective and dangerous by design,

California
United-states
America
Baum-hedlund-aristei-goldman
Los-angeles
Sloan-kettering-zantac
Sloan-kettering
Baum-hedlund
R-brent-wisner
National-law-journal-elite-trial-lawyers
Environmental-protection-agency
National-trial-lawyers

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.